The FY2025 (Dec) proxy of Harmony Biosciences Holdings names 13 peer companies for pay. Among Harmony Biosciences Holdings and these peers, CEO pay was 3rd highest of 4 and total shareholder return was the lowest of 4.
3rd highest of 4in Harmony Biosciences Holdings and its pay peers, FY2025 (Dec) by CEO pay:
$6.9M$24.3M
4th highest of 4in Harmony Biosciences Holdings and its pay peers, FY2025 (Dec) by total shareholder return:
$104$245
Pay peer group, FY2025 (Dec) proxy
| PTC | ||
| Alkermes plc. | ||
| Neurocrine Biosciences | ||
| Acadia | Not disclosed | Not disclosed |
| Avadel | Not disclosed | Not disclosed |
| Axsome | Not disclosed | Not disclosed |
| Catalyst Pharma | Not disclosed | Not disclosed |
| Intra-Cellular | Not disclosed | Not disclosed |
| Ionis | Not disclosed | Not disclosed |
| Jazz Pharmaceuticals | Not disclosed | Not disclosed |
| Marinus | Not disclosed | Not disclosed |
| Sage Therapeutics | Not disclosed | Not disclosed |
| Supernus | Not disclosed | Not disclosed |
13 companies
Changes by year
No proxy on file names a change to the peer group.
The comes from the company's proxy. CEO pay and of each company come from its own Pay versus Performance table for the same fiscal year. Each company counts TSR from its own start year, so two values compare only when the start years match.